Amicus Therapeutics, Inc.
NASDAQ:FOLD
7.98 (USD) • At close September 8, 2025
 Overzicht | Financiële gegevens
 | Bedrijfsnaam | Amicus Therapeutics, Inc. | 
| Symbool | FOLD | 
| Munteenheid | USD | 
| Prijs | 7.98 | 
| Beurswaarde    |  2,459,747,220 | 
| Dividendpercentage    |  0% | 
| 52-weken bereik | 5.51 - 12.65 | 
| Industrie | Biotechnology | 
| Sector | Healthcare | 
| CEO | Mr. Bradley L. Campbell M.B.A. | 
| Website | https://amicusrx.com | 
An error occurred while fetching data.
Over Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in 
 Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)









